Genflow Biosciences (LON:GENF) Shares Down 2.9% – Here’s Why

Genflow Biosciences plc (LON:GENF) was down 2.9% during mid-day trading on Tuesday . The stock traded as low as GBX 2.09 and last traded at GBX 2.09. Approximately 166,975 shares traded hands during trading, a decline of 94% from the average daily volume of 2,691,123 shares. The stock had previously closed at GBX 2.15.

Genflow Biosciences Trading Up 5.7%

The firm’s 50-day moving average price is GBX 1.93 and its 200-day moving average price is GBX 1.89. The stock has a market capitalization of £11.89 million, a PE ratio of -4.42 and a beta of 2.24.

About Genflow Biosciences

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.